Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer
NCT05052099
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Biliary Tract Cancer
Interventions
DRUG:
mFOLFOX6, Atezolizumab and Bevacizumab
Sponsor
University Hospital, Essen